Raymond James Financial Services Advisors’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,270
| Closed | -$30.4K | – | 3444 |
|
|
2024
Q2 | $30.4K | Sell |
2,270
-1,106
| -33% | -$14.8K | ﹤0.01% | 3312 |
|
|
2024
Q1 | $157K | Buy |
3,376
+306
| +10% | +$14.2K | ﹤0.01% | 3150 |
|
|
2023
Q4 | $208K | Sell |
3,070
-28
| -0.9% | -$1.89K | ﹤0.01% | 2960 |
|
|
2023
Q3 | $224K | Buy |
3,098
+1,259
| +68% | +$91.2K | ﹤0.01% | 2852 |
|
|
2023
Q2 | $137K | Buy |
1,839
+35
| +2% | +$2.6K | ﹤0.01% | 3007 |
|
|
2023
Q1 | $96K | Sell |
1,804
-266
| -13% | -$14.2K | ﹤0.01% | 3050 |
|
|
2022
Q4 | $140K | Sell |
2,070
-2,113
| -51% | -$143K | ﹤0.01% | 2948 |
|
|
2022
Q3 | $522K | Buy |
4,183
+3,354
| +405% | +$419K | ﹤0.01% | 2221 |
|
|
2022
Q2 | $79K | Buy |
829
+177
| +27% | +$16.9K | ﹤0.01% | 3029 |
|
|
2022
Q1 | $105K | Buy |
652
+349
| +115% | +$56.2K | ﹤0.01% | 3086 |
|
|
2021
Q4 | $101K | Sell |
303
-134
| -31% | -$44.7K | ﹤0.01% | 3105 |
|
|
2021
Q3 | $203K | Buy |
+437
| New | +$203K | ﹤0.01% | 2964 |
|